Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have hirsutism and skin changes, which indicate a need for metabolic health checks.

Hair changes could indicate neurological diseases and help monitor treatment.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

Teucrium polium extracts are non-toxic and effectively speed up wound healing.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Ethanamizuril is safe for rats at 20 mg/kg feed, but higher doses cause hair loss, organ changes, and liver, kidney, and lung damage.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Human hair protein modifications could potentially indicate heart disease risk.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Mange in camels causes blood and organ damage, especially in older females.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

Physicians in China prioritize clinical hyperandrogenism in PCOS treatment, but clearer guidelines are needed.

Women with PCOS risk had normal height and blood tests but higher weight and common acne or hirsutism.

Laser and cell treatments effectively help hair regrowth in people with focal alopecia.

Oral minoxidil reduced hair shedding in women with chronic telogen effluvium.

Keratin proteins are crucial for hair structure and strength.

The article concludes that better diagnosis and management of Polycystic Ovarian Syndrome are needed to improve women's health and prevent related diseases.